π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
To evaluate the efficacy, safety and survival of two treatment regimens: Co...
Status
Withdrawn
Location
Research Site
Start Date
2004-08
Trial ID
NCT00255268
Treatments Being Tested
The purpose of this study is to evaluate the feasibility, safety and oncolo...
Status
Unknown
Location
Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine
Start Date
2018-09-23
Trial ID
NCT03587285
Treatments Being Tested
Background: Insomnia is associated with difficulty sleeping. The drug zolp...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2019-01-22
Trial ID
NCT03436745
The purpose of this study is to assess the patient's feedback from using Gn...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2022-03-01
Trial ID
NCT05122377
RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, ...
Status
Completed
Location
Beebe Medical Center
Start Date
2000-09
Trial ID
NCT00006359
Treatments Being Tested
The primary purpose of this study is to establish if a 10.8 mg dose of ZOLA...
Status
Completed
Location
Research Site
Start Date
2006-02
Trial ID
NCT00303524
Treatments Being Tested
Phase III clinical trial to study quality of life in prostate cancer patien...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT02382094
Treatments Being Tested
Following a radical prostatectomy and lymph node sampling, eligible patient...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2012-08
Trial ID
NCT00669162
Treatments Being Tested
This phase II trial studies the side effects and how well abiraterone aceta...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2010-03
Trial ID
NCT01023061
The primary objective of this trial is to evaluate ovarian suppression foll...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2026-08-30
Trial ID
NCT07310420
Treatments Being Tested